DNA molecules in moss open door to new biotechnologyNovember 09, 2009Plasmids, which are DNA molecules capable of independent replication in cells, have played an important role in gene technology. Researchers from Uppsala University in Sweden have now demonstrated that plasmid-based methods, which had been limited to single-cell organisms such as bacteria and yeasts, can be extended to mosses, opening the door to applications of a number of powerful techniques in plant research. The findings have been published in the distinguished journal Proceedings of the National Academy of Sciences of the USA (PNAS). Professor Hans Ronne's research team at the Department of Medical Biochemistry and Microbiology at Uppsala University works with the diminutive Physcomitrella moss, which is widely used in research because its genes are easier to "knock out" than those of other plants. Previous work has also shown that DNA introduced into Physcomitrella cells is capable of self-replication through an as yet uncharacterised process. The new study, which was led by Dr. Eva Murén and Ph.D. student Anders Nilsson, shows that plasmids introduced into moss cells can be rescued back to bacteria without affecting the plasmids' original structures, provided that certain conditions are met. Up to now, various kinds of rearrangements have sharply limited the use of plasmids in animal- and plant-cell research. "Our work with plasmids in moss suggests that it will be possible to use powerful methods such as gene cloning by complementation and overexpression directly in plant cells without recourse to single-cell organisms like bacteria or yeasts," says Professor Hans Ronne. "This, in turn, may simplify basic and applied research and biotechnology involving plants." Uppsala University |
|||||||||||||||||||||
| Related Plasmids Current Events and Plasmids News Articles Fate Therapeutics announces creation of small molecule platform for commercial-scale reprogramming Fate Therapeutics, Inc. announced today the generation of human induced-pluripotent stem cells (iPSCs) using a combination of small molecules that significantly improves the speed and efficiency of reprogramming. Geographic isolation drives the evolution of a hot springs microbe Sulfolobus islandicus, a microbe that can live in boiling acid, is offering up its secrets to researchers hardy enough to capture it from the volcanic hot springs where it thrives. Chlamydia that avoids diagnosis New sequencing and analysis of six strains Chlamydia will result in improved diagnosis of the sexually transmitted infection. Evolutionary origin of bacterial chromosomes revealed Researchers have unveiled the evolutionary origin of the different chromosomal architectures found in three species of Agrobacterium. Scientists make malaria parasite work to reveal its own vulnerabilities Researchers seeking ways to defeat malaria have found a way to get help from the parasite that causes the disease. New insights into a leading poultry disease and its risks to human health Biodesign Institute at Arizona State University associate research scientist Melha Mellata, a member of professor Roy Curtiss' team, is leading a USDA funded project to develop a vaccine against a leading poultry disease called avian pathogenic E. coli (APEC). NYU scientists discover dangerous new method for bacterial toxin transfer Scientists have discovered a new way for bacteria to transfer toxic genes to unrelated bacterial species, a finding that raises the unsettling possibility that bacterial swapping of toxins and other disease-aiding factors may be more common than previously imagined. Blocking the spread of antibiotic resistance in bacteria It's as simple as A, T, G, C. Northwestern University scientists have exploited the Watson-Crick base pairing of DNA to provide a defensive tool that could be used to fight the spread of antibiotic resistance in bacteria -- one of the world's most pressing public health problems. Friendly bacteria reduce hospital infections A probiotic bacterium, Lactobacillus plantarum 299, has been used to out-compete the dangerous bacteria that cause respiratory illness in ventilated patients. How to select anti-hepatitis B virus agents for drug-resistance patients? HBV infection may lead to acute liver disease, chronic active hepatitis, liver cirrhosis, and hepatocellular carcinoma. Over 350 million people worldwide are estimated to be infected chronically by HBV and are therefore at risk of liver failure, cirrhosis, or hepatocellular carcinoma. More Plasmids Current Events and Plasmids News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||